0.295
price down icon0.67%   -0.002
pre-market  Pre-market:  .30   0.005   +1.69%
loading
Quoin Pharmaceuticals Ltd Adr stock is traded at $0.295, with a volume of 467.48K. It is down -0.67% in the last 24 hours and down -10.88% over the past month. Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
See More
Previous Close:
$0.297
Open:
$0.3177
24h Volume:
467.48K
Relative Volume:
0.09
Market Cap:
$2.42M
Revenue:
-
Net Income/Loss:
$-8.28M
P/E Ratio:
-0.0531
EPS:
-5.56
Net Cash Flow:
$-7.99M
1W Performance:
-1.73%
1M Performance:
-10.88%
6M Performance:
-50.94%
1Y Performance:
-74.57%
1-Day Range:
Value
$0.2934
$0.3177
1-Week Range:
Value
$0.2703
$0.3177
52-Week Range:
Value
$0.2703
$1.57

Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Company Profile

Name
Name
Quoin Pharmaceuticals Ltd Adr
Name
Phone
97299741444
Name
Address
23 HATA'AS STREET, KFAR SABA
Name
Employee
4
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
QNRX's Discussions on Twitter

Compare QNRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
QNRX
Quoin Pharmaceuticals Ltd Adr
0.295 2.42M 0 -8.28M -7.99M -5.56
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.92 129.14B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
680.61 74.41B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
581.21 35.31B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
241.75 31.30B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
254.57 27.35B 3.32B -860.46M -1.04B -8.32

Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Latest News

pulisher
Mar 04, 2025

QNRX Stock Plummets to 52-Week Low at $0.28 Amid Market Struggles - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

QNRX Stock Plummets to 52-Week Low at $0.28 Amid Market Struggles By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 02, 2025

NVIDIA Corp (NVDA) Shares Up Despite Recent Market Volatility - The News Heater

Mar 02, 2025
pulisher
Feb 27, 2025

Quoin Pharmaceuticals reports promising Netherton Syndrome treatment - Investing.com India

Feb 27, 2025
pulisher
Feb 10, 2025

Stock Performance Spotlight: Quoin Pharmaceuticals Ltd ADR (QNRX) Ends the Day at 0.31, Down by -2.06 - The Dwinnex

Feb 10, 2025
pulisher
Feb 08, 2025

Is Energy Services of America Corp (NASDAQ: ESOA) Poised For Further Gains At A 45.82% Distance From The Low? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Should You Expect Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) To Recover From Its 9.68% Gain From Highs? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Now Is The Time To Build A Position In Health In Tech Inc (NASDAQ:HIT) - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

After A Decline Of -818.6% From The High, Can Evaxion Biotech A/S ADR (NASDAQ: EVAX) Recover Quickly? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

BTC Digital Ltd (NASDAQ: BTCT): Can A Stock Be Up 21.97% YTD, And Still Be A Loser - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

ScanTech AI Systems Inc (NASDAQ: STAI) Gain Of 9.66% Compared To 52-Week Low; YTD Fall -84.49% – What Should You Do Now? – Marketing Sentinel - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Now Is The Time To Build A Position In SolarBank Corporation (NASDAQ:SUUN) - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Aurora Mobile Ltd ADR (NASDAQ: JG) Stock Gained 83.28% Over A Month – Any Room To Run? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Now Is The Time To Build A Position In Atyr Pharma Inc (NASDAQ:ATYR) - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 07, 2025

Berry Global Group Inc [BERY] Records 200-Day SMA of $64.89 - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Quoin Pharmaceuticals Ltd ADR [QNRX] stock for 250,000 USD was acquired by Carter Denise P. - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

INVZ Shares Experience Surge in Value - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Jefferies Financial Group Inc [JEF] Shares Rise 1.55 % on Thursday - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

DHT Holdings Inc [DHT] Shares Jump Approximately 9.62% Over the Year - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Now Is The Time To Build A Position In American Battery Technology Company (NASDAQ:ABAT) - Marketing Sentinel

Feb 07, 2025
pulisher
Feb 06, 2025

After Jumping 10.61% During The Past Week, Should You Still Buy Recursion Pharmaceuticals Inc (NASDAQ: RXRX)? - Marketing Sentinel

Feb 06, 2025
pulisher
Feb 06, 2025

Beyond Inc (NYSE: BYON) Has Succeeded In Generating Interest In 2025, The Stock Is Up 87.02% Year-To-Date - Marketing Sentinel

Feb 06, 2025
pulisher
Feb 06, 2025

Orangekloud Technology Inc (NASDAQ: ORKT) Up 58.11% From 52-Week Low; YTD Falls -50.99% – Here’s What To Do Now – Marketing Sentinel - Marketing Sentinel

Feb 06, 2025
pulisher
Feb 05, 2025

Market cap of Captivision Inc [CAPT] reaches 33.99M – now what? - The DBT News

Feb 05, 2025
pulisher
Feb 05, 2025

Citigroup lifts StoneCo Ltd [STNE] price estimate. Who else is bullish? - The DBT News

Feb 05, 2025
pulisher
Feb 05, 2025

PDD Holdings Inc ADR (NASDAQ: PDD): How To Buy And When To Buy And Its Performance & Trends - Marketing Sentinel

Feb 05, 2025
pulisher
Feb 04, 2025

Quoin Pharmaceuticals launches Netherton awareness campaign - Investing.com India

Feb 04, 2025
pulisher
Feb 04, 2025

Understanding QNRX’s financial ratios: A beginner’s guide - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

An Overview of Castellum Inc (AMEX: CTM)’s Stock Performance and Outlook - Marketing Sentinel

Feb 04, 2025
pulisher
Feb 03, 2025

Why Should You Invest In Castellum Inc (AMEX: CTM)? - Marketing Sentinel

Feb 03, 2025
pulisher
Feb 01, 2025

FTAI Infrastructure Inc (NASDAQ:FIP) Shares Dropped -1.13% In A Week. Can It Continue Rising? - Marketing Sentinel

Feb 01, 2025
pulisher
Feb 01, 2025

Capricor Therapeutics Inc (NASDAQ:CAPR) Decline -1.05%, More Rally Possible - Marketing Sentinel

Feb 01, 2025
pulisher
Jan 31, 2025

Earnings call transcript: Quoin Pharmaceuticals Q4 2023 sees stock volatility - MSN

Jan 31, 2025
pulisher
Jan 29, 2025

AST SpaceMobile Inc (ASTS) Investors Will See A Big Return Again - Marketing Sentinel

Jan 29, 2025
pulisher
Jan 28, 2025

Why Acquire Shares Of Castellum Inc (CTM)? - Marketing Sentinel

Jan 28, 2025
pulisher
Jan 25, 2025

Syros Pharmaceuticals Inc (NASDAQ: SYRS) Fell -2280.95%, Predicting What To Expect In The Near Future - Marketing Sentinel

Jan 25, 2025
pulisher
Jan 23, 2025

Sobr Safe Inc (NASDAQ: SOBR) Fall -93.95% In Six Months, Here’s What We Should Expect Now - Marketing Sentinel

Jan 23, 2025
pulisher
Jan 22, 2025

Future Prospects And Stock Pricing Of DatChat Inc (NASDAQ: DATS) - Marketing Sentinel

Jan 22, 2025
pulisher
Jan 21, 2025

Future Outlook And Stock Price Performance For Zeo Energy Corp (NASDAQ: ZEO) - Marketing Sentinel

Jan 21, 2025
pulisher
Jan 20, 2025

Future Outlook And Stock Price Performance For Evaxion Biotech A/S ADR (NASDAQ: EVAX) - Marketing Sentinel

Jan 20, 2025
pulisher
Jan 18, 2025

Now Is The Time To Build A Position In Pony AI Inc. ADR (NASDAQ:PONY) - Marketing Sentinel

Jan 18, 2025
pulisher
Jan 17, 2025

Should You Expect Humacyte Inc (NASDAQ:HUMA) To Recover From Its 44.64% Gain From Highs? - Marketing Sentinel

Jan 17, 2025
pulisher
Jan 16, 2025

Now Is The Time To Build A Position In MGO Global Inc (NASDAQ:MGOL) - Marketing Sentinel

Jan 16, 2025
pulisher
Jan 15, 2025

Now Is The Time To Build A Position In XORTX Therapeutics Inc (NASDAQ:XRTX) - Marketing Sentinel

Jan 15, 2025
pulisher
Jan 14, 2025

Quoin reports progress in pediatric skin disorder study - Investing.com

Jan 14, 2025
pulisher
Jan 14, 2025

Worksport Ltd (NASDAQ: WKSP) Is Under Pressure Due To Weak Fundamental Momentum. - Marketing Sentinel

Jan 14, 2025
pulisher
Jan 11, 2025

Third Harmonic Bio Inc (NASDAQ:THRD) Shares Rebounded 3.35% From Their Lows – But Can They Continue? - Marketing Sentinel

Jan 11, 2025
pulisher
Jan 10, 2025

fuboTV Inc (NYSE:FUBO) Shares Surged 288.30% In A Week – But Will They Keep Going Up? - Marketing Sentinel

Jan 10, 2025
pulisher
Jan 09, 2025

Now Is The Time To Build A Position In Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) - Marketing Sentinel

Jan 09, 2025
pulisher
Jan 07, 2025

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials - GlobeNewswire Inc.

Jan 07, 2025
pulisher
Jan 07, 2025

Analysts Are Recommending Greenwave Technology Solutions Inc (GWAV) As A Buy Candidate - Marketing Sentinel

Jan 07, 2025

Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Cap:     |  Volume (24h):